The role of the pharmacist in the COVID-19 pandemic: An integrative review
Keywords:Coronavirus; COVID-19; Pharmacy service; Pharmaceutical care; Hospital pharmacy.
Objective: To analyze the scientific literature regarding the role of the pharmacist in the COVID-19 pandemic, through an integrative literature review. Data source: The search for scientific articles was carried out in the following databases: Virtual Health Library (VHL), Latin American and Caribbean Literature in Health Sciences (LILACS), Scientific Eletronic Library Online (SciELO) and PubMed in period from 2019 to 2020. The inclusion criteria established were publications in English with the descriptor “Coronavirus, COVID-19, Pharmacy, Community Pharmacy, Pharmacy Services, Pharmaceutical Care, Hospital Pharmacy” in the title, abstract or keywords in available articles online and in full. Letters to the editor and duplicate articles were excluded. Summary of the findings: 10,906 articles were identified, of which 28 met the selection criteria. The results were demonstrated with emphasis on the additional functions performed by pharmacists both in the community pharmacy and in the hospital pharmacy, determined by the pandemic situation. At the hospital level, support for clinical decision-making on pharmacotherapy, logistical management of medications, greater security in dispensing medication and pharmacovigilance were verified. In the community pharmacy environment, the emphasis was on pharmaceutical care directly to the user through guidance on hygiene measures seeking to minimize or prevent the spread of the virus and contamination of people. Maintaining the dispensing of medications for acute and chronic users, by guaranteeing the supply and availability of quality medications, was the main activity, as well as rapid tests for diagnoses of COVID-19.
Al-Quteimat, O., Amer, A. M. (2021). SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm, 17(2), 480-482. https://doi.org/10.1016/j.sapharm.2020.03.018.
Alderman, C. Pharmacy Services and the Novel Coronavirus. (2020). Sr Care Pharm, 35(4), 146-147. https://doi.org/10.4140/TCP.n.2020.146
Amariles, P., Ledezma-Morales, M., Salazar-Ospina, A., Hincapié-Garcia, J. A., (2021). How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Social Adm Pharm, 17(1), 1988-1989. https://doi.org/10.1016/j.sapharm.2020.03.007.
Arain,S., Thalapparambayh, R., Al Ghandi, F. H. (2020). COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department. Res Social Adm Pharm, 17(1), 2009-2011.
Bahlol, M., Dewey, R. S. (2020). Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm, 17(1), 1888-1898. https://doi.org/10.1016/j.sapharm.2020.05.009.
Basheti,I. A., Nassar, R., Barakat, M., Alqudah, R., Abufarha, T., Mukattash, L., Saini, B. (2020). Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles. Res Social Adm Pharm, 17(3), 514-522. https://doi.org/10.1016/j.sapharm.2020.04.020.
Bukhari, N., Rasheed, U., Nayyer, B., Babar, Z. U. D. (2020). Pharmacists at the frontline beating the COVID-19 pandemic. J of Pharm Policy and Pract 13, 8 (2020). https://doi.org/10.1186/s40545-020-00210-w.
Cadogan, C. A., Hughes, C. M. (2020). On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Res Social Adm Pharm, 17(3), 514-522. DOI:10.1186/s40545-020-00210-w
Carico, R., Sheppatd, J., Thomas, C. B. (2021). Community pharmacists and communication in the time of COVID-19: Applying the health belief model. Res Social Adm Pharm, 17(1), 1984-1987. https://doi.org/10.1016/j.sapharm.2020.03.017.
Dawoud, D. (2021). Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Res Social Adm Pharm, 17(1): 1950–1953. https://doi.org/10.1016/j.sapharm.2020.05.011.
Erku, D. A., Belachew, S. A., Abrha, S., Sinnollareddy, M., Thomas, J., Steadman, K. J., Tesfaye, H. (2020). When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the “infodemic” surrounding COVID-19. Res Social Adm Pharm, 17(1), 1954-1963. https://doi.org/10.1016/j.sapharm.2020.04.032.
Fitzgerald, T.J. Kang, Y., Bridges, C. B., Talbert, T., Vagi, S. J., Lamont, B., Gratcer, S. B. (2016). Integrating pharmacies into public health program planning for pandemic influenza vaccine response. Vaccine, 34(46), 5643–5648. https://doi.org/10.1016/j.vaccine.2016.09.020.
Hedima, E. W., Adeyemi, M. S,m Ikunaiye, N. Y.(2020). Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Res Social Adm Pharm, 17(1), 1964-1966. https://doi.org/10.1016/j.sapharm.2020.04.013
Hua, X. L., Gu, M., Zeng, F., Hu, H., Zhou, T., Zhang, Y., Shi, C. (2020) Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc, 60(3), 431- 438. https://doi.org/10.1016/j.japh.2020.04.006.
Hussain, R., Dawoud, D. M., Babar, Z. U. D. (2020). Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic. Res Social Adm Pharm, 17(1), 1920-1924. https://doi.org/10.1016/j.sapharm.2020.07.015.
International Pharmaceutical Federation (FIP Health Advisory). Coronavirus 2019-nCoV Outbreak. Information and interim guidelines for pharmacists and the pharmacy workforce. Netherlands, 2020. Disponível em:: https://www.fip.org/files/content/priority-areas/coronavirus/Coronavirus-guidance-update-ENGLISH.pdf. Acesso em: 30 out 2020.
Jiang,S. Death Toll Rises to 25. CNN; 2020. Disponível em: https://edition.cnn.com/asia/live-news/coronavirus-outbreak-intl-hnk/index.html. Acesso em: 29 out 2020.
Koster, E., Philbert, D., Bouvy, M. L.(2021). Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm,17(1), 2002-2004.
Li, H., Sigian, Z., Fang, L., Wei, L., Rongsheng, Z. (2021) Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm, 17(1), 1813-1818. https://doi.org/10.1016/j.sapharm.2020.07.001.
Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm, 42(2):299-304.
Lu, C., Liu, X., Jia, Z. (2020). 2019-nCoV transmission through the ocular surface must not be ignored.
Lancet, 22(395) (10224):e39. https://doi.org/10.1016/S0140-6736(20)30313-5.
Meng, L., Qiu, F., Sun, S. (2020). Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China. Int J Clin Pharm, 2 : 1–4. https://doi.org/10.1007/s11096-020-01020-5.
Santos, L. E. S. dos; Santos, L. S. dos. (20210. The impact of the coronavirus on patients with heart diseases. Research, Society and Development, 10(5), e0110514539.
Sethuraman, N., (2020). Interpreting diagnostic tests for SARS-CoV-2. JAMA. 6, 2020. https://doi.org/10.1001/jama.2020.8259.
Song, Z., Hu, Y., Zheng, S., Yang, L., Zhao, R. (2021). Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Res Social Adm Pharm, 17(1):2027-2031. https://doi.org/10.1016/j.sapharm.2020.03.027.
Souza, M. T., Silva, M. D., Carvalho, R. (2010). Integrative review: what is it? How to do it?. Einstein, 6(1), 102-6. https://doi.org/10.1590/s1679-45082010rw1134
Stergachis, A. (2020). Preparing pharmacy for the surge of patients with COVID-19: Lessons from China. J Am Pharm Assoc, 60(3): 423–424. https://doi.org/10.1016/j.japh.2020.04.005.
Sum, Z. Z., OW, C. J. W. (2021). Community pharmacy response to infection control during COVID-19. A cross-sectional survey. Res Social Adm Pharm, 17(1):1845-1852.
The Straits Times. First Death outside China in Philippines; 2020. Published https ://www.straitstimes.com/asia/se-asia/first-death-outside-china-in-philippines. Acesso em: 28 out 2020.
Ung, C. O. L. (2020). Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm, 16(4):583-586.
Uzunian, A. (2020). Coronavírus SARS-CoV-2 e COVID-19. J Bras Patol Med Lab, 56: 1-4.
Vellano, P. O., Paiva, M. J. M. (2020). O uso de antimicrobiano na COVID-19 e as infecções: o que sabemos. Research, Society and Development, 9(6), e841997245. http://dx.doi.org/10.33448/rsd-v9i9.7245
Visacri, M. B., Figueiredo, I. V., Lima, T. M.(2021). Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Social Adm Pharm, 17(1), 1799-1806. https://doi.org/10.1016/j.sapharm.2020.07.003.
Wiersinga, W. J., Rodhes, A., Cheng, A. C., Peacock, S., Prescott, H. C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 324(8), 782-793. https://doi.org/10.1001/jama.2020.12839.
World Health Organization. Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations. https://www.who.int/news-room/commentaries/detail/m odes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-r ecommendations. Acesso em: 28 out 2020.
Ying,W., Qian, Y., Kun, Z. (2021). Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm, 17(1), 1978-1983.
World Heath Organization. Coronavirus Disease (COVID-19) - events as they happen. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Acesso em: 28 out 2020.
World Heath Organization. Coronavirus disease 2019 (COVID-19) - situation report – 72. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200401-sitrep-72-c ovid-19.pdf?sfvrsn¼3dd8971b_2; 2020b. Acesso em: 28 out 2020.
Zaidi, S. T. R., Hasan, S., Saidi, S. T. R., Hasan, S. S.(2020). Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm, 17(1), 1832-1837. https://doi.org/10.1016/j.sapharm.2020.07.006.
Zheng, S., Yang, L., Zhou, P. X., Li, H., Liu, F. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm, 17(1), 1819-1824. https://doi.org/10.1016/j.sapharm.2020.03.012
Zuckerman, A. D., (2020). From natural disaster to pandemic: A health-system pharmacy rises to the challenge. Am J Health Syst Pharm, 77(23), 1986–1993. https://doi.org/10.1093/ajhp/zxaa180.
How to Cite
Copyright (c) 2021 Márcia Maria Barros dos Passos; Vivien de Moraes Castoldi; Orenzio Soler
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.